Skip to main content

Regulatory Review of New Therapeutic Agents - FDA versus EMA, 2011-2015.

Publication ,  Journal Article
Downing, NS; Zhang, AD; Ross, JS
Published in: The New England journal of medicine
April 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

The New England journal of medicine

DOI

EISSN

1533-4406

ISSN

0028-4793

Publication Date

April 2017

Volume

376

Issue

14

Start / End Page

1386 / 1387

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Time Factors
  • General & Internal Medicine
  • Europe
  • Drug Approval
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Downing, N. S., Zhang, A. D., & Ross, J. S. (2017). Regulatory Review of New Therapeutic Agents - FDA versus EMA, 2011-2015. The New England Journal of Medicine, 376(14), 1386–1387. https://doi.org/10.1056/nejmc1700103
Downing, Nicholas S., Audrey D. Zhang, and Joseph S. Ross. “Regulatory Review of New Therapeutic Agents - FDA versus EMA, 2011-2015.The New England Journal of Medicine 376, no. 14 (April 2017): 1386–87. https://doi.org/10.1056/nejmc1700103.
Downing NS, Zhang AD, Ross JS. Regulatory Review of New Therapeutic Agents - FDA versus EMA, 2011-2015. The New England journal of medicine. 2017 Apr;376(14):1386–7.
Downing, Nicholas S., et al. “Regulatory Review of New Therapeutic Agents - FDA versus EMA, 2011-2015.The New England Journal of Medicine, vol. 376, no. 14, Apr. 2017, pp. 1386–87. Epmc, doi:10.1056/nejmc1700103.
Downing NS, Zhang AD, Ross JS. Regulatory Review of New Therapeutic Agents - FDA versus EMA, 2011-2015. The New England journal of medicine. 2017 Apr;376(14):1386–1387.

Published In

The New England journal of medicine

DOI

EISSN

1533-4406

ISSN

0028-4793

Publication Date

April 2017

Volume

376

Issue

14

Start / End Page

1386 / 1387

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Time Factors
  • General & Internal Medicine
  • Europe
  • Drug Approval
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences